Page 3 - Biotechnology

North India's first Industrial Biotech Park inaugurated at Kathua in J&K

Jammu and Kashmir (J&K) Lieutenant Governor, Manoj Sinha and Union minister Jitendra Singh on Saturday inaugurated the north India's first Industrial Biotech Park constructed at Ghatti near Kathua.

Samsung to spend $360 billion on microchips, biotech over five years

Samsung promised in a statement to create 80,000 jobs through 2026, mostly in semiconductors and biopharmaceuticals.

Ireland regulator reports manufacturing deficiency at Biocon's plant

Biocon Biologics is a subsidiary of Biocon Ltd

Indian-American Congressman Ro Khanna named to National Security Commission

Indian-American Congressman Ro Khanna was on Thursday named to the National Security Commission on Emerging Biotechnology

Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall

The company in a statement said that its subsidiary Biocon Biologics has inked a pact to acquire Viatris Inc's biosimilars business for consideration of up to USD 3.335 billion

Covid vaccine sales push Moderna to $12-bn profit in 2021

The vaccine maker's COVID-19 shots, which are now available in more than 70 countries, totalled USD 17.7 billion in sales last year, their first full year on the market

Gujarat chief minister Bhupendra Patel unveils new biotechnology policy

CM Bhupendra Patel unveiled a new biotechnology policy for the next five years that seeks to make Gujarat one of the leading states in the country in the key sector

Biocon rises over 3% as biotech major sees strong Dec qtr numbers

Notwithstanding the muted broader market trend, shares of Biocon Ltd surged over 3 per cent on Friday after the biotechnology major reported strong December quarter earnings. On BSE, the stock opened at Rs 363, then touched a high of Rs 382.45, registering a gain of 5.09 per cent over its last close. The stock finally ended at Rs 376.60, up 3.49 per cent. In a similar trend on NSE, the stock opened at Rs 364.00, then jumped 5.02 per cent and touched an early high of Rs 382.50 in initial deals. It finally settled at Rs 376.45, up 3.36 per cent. On Thursday, biotechnology major Biocon Ltd reported a 17.68 per cent rise in consolidated net profit at Rs 219.6 crore for the third quarter ended December 31, 2021. The company had posted a consolidated net profit of Rs 186.6 crore in the same quarter of the previous fiscal. Consolidated total income in the third quarter this fiscal stood at Rs 2,222.5 crore, compared to Rs 1,885.3 crore a year ago. The biosimilars vertical clocked revenue

Biotech firm Mylab developing test to screen multiple Covid variants

Mylab MD Rawal said the firm is making both hardware and software for the test, and it will be ready in the next two months or so

Rajasthan becomes 1st state to develop facility for Genome Sequencing

The facility for genome Sequencing has been started in the SMS Medical College

Biotechnology firm Mylab ropes in Akshay Kumar as brand ambassador

The Pune-based firm, which has a presence across many verticals like diagnostics, food safety, agriculture and veterinary medicine

This biotech engineer is on a mission to create human organs using 3D tech

Her startup has so far handled 1,400 cases making 3D models of patients' body parts, assisting doctors to study the organ without opening up the patient in the operation theatre

A peek into the startup incubation drives of India's next-rung campuses

Not all great ideas are nurtured at IITs and IIMs; many enterprises with formidable products today have come from the country's deeper regions and have received parenting at lesser known institutes

SoftBank to invest $900 million in gene sequencing firm Pacific Biosciences

Pacific Biosciences of California Inc said on Wednesday SoftBank Group Corp will invest $900 million in the gene sequencing firm

Praj Industries bags Rs 226 crore order from Indian Oil Corporation

Industrial biotechnology company Praj Industries on Friday said it has bagged a Rs 226.90 crore order from Indian Oil Corporation Ltd

Karnataka aims to become a $50-bn bio-economy by 2025: Deputy CM

Bio-economy uses renewable biological resources sustainably to produce food, energy and industrial goods.

Adding value to your food

There are speculations on whether the government's policy on genetically engineered products has undergone a subtle, even if undeclared, change. If it is so, it is welcome

Sanofi offers to buy Dutch biotechnology firm Kiadis for $358.4 million

Kiadis owns a platform based on a so-called "allogeneic natural killer" that can seek and identify malignant cancer cells

Pfizer, BioNTech to expand phase three trial for coronavirus vaccine

The US Food and Drug Administration (FDA) will have to approve the change in the Phase 3 Covid-19 vaccine trial before it goes into effect

Sanofi snags US biotech asset with $3.7 bn deal for Principia Biopharma

PARIS (Reuters) - Sanofi SA is to buy U.S.-based Principia Biopharma Inc for around $3.7 billion, the companies announced on Monday, marking the French healthcare company's latest acquisition in the biotech sector.